Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

NCT03084952 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Leishmaniasis; American, Cutaneous
Drug Side Effect

Interventions

DRUG: 18-Methoxycoronaridine
DRUG: Glucantime

Sponsor

Infan Industria Quimica Farmaceutica Nacional